Epidemiology of breast cancer

Lancet Oncology

Volumn 2, Issue 3, 2001, Pages 133-140

  Key, Timothy J ^a   Verkasalo, Pia K ^a   Banks, Emily ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; BREAST TUMOR; DIET; FEMALE; HORMONE SUBSTITUTION; HUMAN; MIDDLE AGED; MUTATION; REVIEW; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; DIET; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; MUTATION; RISK FACTORS;

EID: 0035295772     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(00)00254-0     Document Type: Review

References (50)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 349:1997;1269-1276.
2. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet. 350:1997;1047-1059.
3. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 85:1993;1819-1827.
4. Hoel DG, Wakabayashi T, Pike MC. Secular trends in the distributions of the breast cancer risk factors - menarche, first birth, menopause, and weight - in Hiroshima and Nagasaki, Japan. Am J Epidemiol. 118:1983;78-89.
5. Coleman MP, Sloggett A, Babb P, et al. Trends in breast cancer incidence, survival, and mortality. Lancet. 356:2000;590-591.
6. Peto R, Boreham J, Clarke M, et al. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet. 355:2000;1822.
7. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 15:1993;36-47.
8. Hunter DJ, Spiegelman D, Adami H-O, et al. Non-dietary factors as risk factors for breast cancer, and as effect modifiers of the association of fat intake and risk of breast cancer. Cancer Causes Control. 8:1997;49-56.
9. Beral V, Reeves G. Childbearing, oral contraceptive use, and breast cancer. Lancet. 341:1993;1102.
10. Layde PM, Webster LA, Baughman AL, et al. The independent associations of parity, age at first full term pregnancy, and duration of breast feeding with the risk of breast cancer. J Clin Epidemiol. 42:1989;963-973.
11. Ewertz M, Duffy S, Adami H-O, et al. Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from Nordic countries. Int J Cancer. 46:1990;597-603.
12. Lipworth L, Bailey LR, Trichopoulos D. History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst. 92:2000;302-312.
13. Key TJ, Verkasalo PK. Endogenous hormones and the aetiology of breast cancer. Breast Cancer Res 1999, htpp://breast-cancer-research.com/vol1no1/23aug99/editorial/2.
14. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet. 347:1996;1713-1727.
15. Magnusson CM, Baron J, Correia N, et al. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer. 81:1999;339-344.
16. Schairer C, Lubin J, Troisi R, et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 283:2000;485-491.
17. Ross RK, Paganini-Hill A, Wan PC, et al. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 92:2000;328-332.
18. Malone KE. Diethylstilbestrol (DES) and breast cancer. Epidemiol Rev. 15:1993;108-109.
19. Venn A, Watson L, Bruinsma F, et al. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet. 354:1999;1586-1590.
20. Bodian CA. Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev. 15:1993;177-187.
21. Boyd NF, Lockwood GA, Byng JW, et al. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 7:1998;1133-1144.
22. Hunter DJ, Spiegelman D, Adami H-O, et al. Cohort studies of fat intake and the risk of breast cancer - a pooled analysis. N Engl J Med. 334:1996;356-361.
23. Gandini S, Merzenich H, Robertson C, et al. Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer. 36:2000;636-646.
24. Key TJ, Fraser GE, Thorogood M, et al. Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76,000 men and women in five prospective studies. Public Health Nutr. 1:1998;33-41.
25. Key TJ, Sharp GB, Appleby PN, et al. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer. 81:1999;1248-1256.
26. Smith-Warner SA, Spiegelman D, Yaun S-S, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 279:1998;535-540.
27. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev. 15:1993;110-132.
28. Michels KB, Trichopoulos D, Robins JM, et al. Birthweight as a risk factor for breast cancer. Lancet. 348:1996;1542-1546.
29. Friedenreich CM, Thune I, Brinton LA, et al. Epidemiologic issues related to the association between physical activity and breast cancer. Cancer. 83:1998;600-610.
30. Boice JD, Land CE, Preston DL. Ionizing radiation. Shottenfeld D, Fraumeni JF. Cancer epidemiology and prevention. 1996;319-354 Oxford University Press, New York.
31. Little MP, Boice JD. Comparison of breast cancer incidence in the Massachusetts fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res. 151:1999;218-224.
32. Doody MM, Mandel JS, Lubin JH, et al. Mortality among United States radiologic technologists, 1926-90. Cancer Causes Control. 9:1998;67-75.
33. Evans JS, Wennberg JE, McNeil BJ. The influence of diagnostic radiography on the incidence of breast cancer and leukemia. N Engl J Med. 315:1986;810-815.
34. Stevens RG. Electric power use and breast cancer: a hypothesis. Am J Epidemiol. 125:1987;556-561.
35. Forssen UM, Feychting M, Rutqvist LE, et al. Occupational and residential magnetic field exposure and breast cancer in females. Epidemiology. 11:2000;24-29.
36. Dich J, Zahm SH, Hanberg A, et al. Pesticides and cancer. Cancer Causes Control. 8:1997;420-443.
37. Wolff MS, Zeleniuch-Jacquotte A, Dubin N, et al. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev. 9:2000;271-277.
38. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer. N Engl J Med. 343:2000;78-85.
39. Pharoah PDP, Day NE, Duffy S, et al. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer. 71:1997;800-809.
40. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet. 62:1998;334-345.
41. Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Res 1999, htpp://breast-cancer-research.com/vol1no1/23aug99/editorial/1.
42. Peto J, Collins N, Barfoot R, et al. The prevalence of BRCA1 and BRCA2 mutations amongst early onset breast cancer cases in the UK. J Natl Cancer Inst. 91:1999;943-949.
43. Thorlacius S, Struewing JP, Hartge P, et al. Population based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet. 352:1998;1337-1339.
44. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 336:1997;1401-1408.
45. Dunning AM, Healey CS, Teare MD, et al. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 8:1999;843-854.
46. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 351:1998;1451-1467.
47. Pritchard KI. Is tamoxifen effective in prevention of breast cancer? Lancet. 352:1998;80-81.
48. Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women. JAMA. 281:1999;2189-2197.
49. Russo J, Russo IH. Cellular basis of breast cancer susceptibility. Oncol Res. 11:1999;169-178.
50. Trentham-Dietz A, Newcomb PA, Storer BE, et al. Body size and risk of breast cancer. Am J Epidemiol. 145:1997;1011-1019.